BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

284 related articles for article (PubMed ID: 1082894)

  • 1. Regualtion of the immune response to tumor antigens. I. Immunosuppressor cells in tumor-bearing hosts.
    Fujimoto S; Greene MI; Sehon AH
    J Immunol; 1976 Mar; 116(3):791-9. PubMed ID: 1082894
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Regulation of the immune response to tumor antigens. II. The nature of immunosuppressor cells in tumor-bearing hosts.
    Fujimoto S; Greene MI; Sehon AH
    J Immunol; 1976 Mar; 116(3):800-6. PubMed ID: 1254955
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Immunosuppressor T cells in tumor bearing host.
    Fujimoto S; Greene M; Sehon AH
    Immunol Commun; 1975; 4(3):201-17. PubMed ID: 1080741
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Regulation of the immune response to tumor antigens. III. Characterization of thymic suppressor factor(s) produced by tumor-bearing hosts.
    Greene MI; Fujimoto S; Sehon AH
    J Immunol; 1977 Aug; 119(2):757-64. PubMed ID: 69667
    [TBL] [Abstract][Full Text] [Related]  

  • 5. In vitro reactivity of splenic lymphocytes from normal and UV-irradiated mice against syngeneic UV-induced tumors.
    Fortner GW; Kripke ML
    J Immunol; 1977 Apr; 118(4):1483-7. PubMed ID: 66296
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Presence of suppressor cells in spleens of mice bearing a weakly immunogenic syngeneic tumor.
    Gautam SC; Deodhar SD
    Cancer Res; 1979 Aug; 39(8):2945-51. PubMed ID: 313243
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Immunological activity of regional lymph nodes in tumor-bearing mice.
    Barna BP; Deodhar SD
    Cancer Res; 1979 Jul; 39(7 Pt 1):2711-7. PubMed ID: 312691
    [TBL] [Abstract][Full Text] [Related]  

  • 8. In vitro stimulation and inhibition of tumor cell growth mediated by different lymphoid cell populations.
    Norbury KC
    Cancer Res; 1977 May; 37(5):1408-15. PubMed ID: 66982
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Immune response of mice to sarcoma I allograft studied by adoptive transfers of spleen, thymus, and lymph node cells to secondary recipients.
    Vidrnová M; Nouza K; Panajotovová V
    Neoplasma; 1985; 32(4):451-61. PubMed ID: 4047256
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Transfer of immunity by transfer of bone marrow cells: a requirement for T lymphocytes and sensitivity to cyclophosphamide.
    Marusić M
    Exp Hematol; 1978 Oct; 6(9):725-37. PubMed ID: 361429
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Antibody-mediated suppression of grafted lymphoma. III. Evaluation of the role of thymic function, non-thymus-derived lymphocytes, macrophages, platelets, and polymorphonuclear leukocytes in syngeneic and allogeneic hosts.
    Shin HS; Hayden M; Langley S; Kaliss N; Smith MR
    J Immunol; 1975 Apr; 114(4):1255-63. PubMed ID: 1078832
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Regulation of Ia+ reticulum cell sarcoma (RCS) growth in syngeneic SJL/J mice. I. Inhibition of tumor growth by passive administration of L3T4 monoclonal antibody before or after tumor inoculation.
    Ohnishi K; Bonavida B
    J Immunol; 1987 Jun; 138(12):4524-9. PubMed ID: 2953807
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Augmentation of specific cell-mediated immune responses to tumor cells in tumor-bearing rats pretreated wih the antileukemia drug busulfan.
    Mizushima Y; Sendo F; Miyake T; Kobayashi H
    J Natl Cancer Inst; 1981 Apr; 66(4):659-65. PubMed ID: 6939913
    [TBL] [Abstract][Full Text] [Related]  

  • 14. T-cell involvement in adoptive transfer of line 10 tumor immunity in strain 2 guinea pigs.
    de Jong WH; Steerenberg PA; van de Plas MM; Kruizinga W; Ruitenberg J
    J Natl Cancer Inst; 1985 Sep; 75(3):483-9. PubMed ID: 3875751
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A syngeneic metastatic tumor model in mice: the natural immune response of the host and its manipulation.
    Treves AJ; Cohen IR; Feldman M
    Isr J Med Sci; 1976; 12(4-5):369-84. PubMed ID: 1084880
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Neonatal susceptibility to MHV3 infection in mice. I. Transfer of resistance.
    Levy-Leblond E; Dupuy JM
    J Immunol; 1977 Apr; 118(4):1219-22. PubMed ID: 300403
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Rejection of mammary adenocarcinoma cell tumors in DBA/2 mice immunocompromised by thymectomy and treatment with antithymocyte serum.
    Likhite VV
    J Immunol; 1975 Jun; 114(6):1736-42. PubMed ID: 1092759
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Activation of suppressor cells by syngeneic tumor transplants in mice.
    Argyris BF
    Cancer Res; 1978 May; 38(5):1269-73. PubMed ID: 147732
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Studies of allogeneic tumor transplants: induced rejection of advanced tumors by immune alteration of recipients.
    Russell PS; Chase CM; Burton RC
    J Immunol; 1983 Feb; 130(2):951-7. PubMed ID: 6336775
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cellular basis of immunologic interactions in adoptive T cell therapy of established metastases from a syngeneic murine sarcoma.
    Ward BA; Shu S; Chou T; Perry-Lalley D; Chang AE
    J Immunol; 1988 Aug; 141(3):1047-53. PubMed ID: 3260908
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.